Certified Addiction Counselor (CAC) Practice

The regulation of 42 CFR, specifically part 2, pertains to the confidentiality of substance use disorder patient records. This section establishes guidelines for the protection of patient information related to drug abuse and treatment, requiring consent from patients before their information can be disclosed. The essence of this regulation is to encourage individuals to seek treatment without the fear of stigma or breach of confidentiality, thus fostering an environment where individuals can pursue recovery more openly.

The other options revolve around important aspects of drug and health management but do not align with the specific focus of 42 CFR. Contracts for drug sales relate more to business and legal regulations rather than patient confidentiality. Drug manufacturing standards involve quality control and safety regulations that fall under the purview of agencies like the FDA. Public health campaigns address broader health issues and awareness initiatives that are distinct from the specific focus on patient records concerning substance use disorders governed by 42 CFR.